Cecilia Soriano is the Group President, Infusion Therapies & Technologies and Pharmaceuticals at Baxter International Inc., a global healthcare company focused on advancing patient care through innovative therapies and technologies. In this role, she leads a diverse portfolio that includes infusion pumps, vascular access solutions, pharmacy compounding systems, and pharmaceutical products, driving strategic growth and operational excellence to support hospitals and clinicians worldwide. Soriano's leadership emphasizes patient safety, digital innovation, and sustainable healthcare solutions, positioning Baxter as a leader in critical care delivery. With more than 25 years of experience in the medical device and pharmaceutical industries, Soriano joined Baxter in 2021 after a distinguished 18-year tenure at Becton, Dickinson and Company (BD), where she rose to Executive Vice President and President of Medication Delivery Solutions. At BD, she spearheaded the Peripheral IV and Advanced Technology Solutions business, achieving double-digit revenue growth, expanding global market share, and launching breakthrough products in vascular access and infusion technologies. Earlier in her career, she held progressive leadership roles at CareFusion (acquired by BD), honing her expertise in respiratory care, surgical navigation, and enterprise software solutions. Under Soriano's stewardship at Baxter, the Infusion Therapies & Technologies and Pharmaceuticals group has delivered key achievements, including the successful integration of Hillrom's surgical portfolio post-acquisition, accelerated development of next-generation infusion systems like the DoseEdge Pharmacy Workflow Manager, and expanded access to essential pharmaceuticals amid global supply challenges. Recognized for her transformative impact, Soriano continues to champion diversity, innovation, and customer-centric strategies that enhance clinical outcomes and operational efficiency.